To include your compound in the COVID-19 Resource Center, submit it here.

4SC grants Maruho rights to KCNA3-targeted compounds

4SC AG (Xetra:VSC) granted Maruho Co. Ltd. (Osaka,

Read the full 87 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE